Abstract:Parkinson's disease (PD) is a common age-related neurodegenerative disorder characterized by the aggregation of α-Synuclein (αSYN) building up intraneuronal inclusions termed Lewy pathology. Mounting evidence suggests that neuron-released αSYN aggregates could be central to microglial activation, which in turn mounts and orchestrates neuroinflammatory processes potentially harmful to neurons. Therefore, understanding the mechanisms that drive microglial cell activation, polarization and function in PD might have important therapeutic implications. Here, using primary microglia, we investigated the inflammatory potential of pure αSYN fibrils derived from PD patients. We further explored and characterized microglial cell responses to a chronic-type inflammatory stimulation combining PD patient-derived αSYN fibrils (F PD ), Tumor necrosis factor-α (TNFα) and prostaglandin E 2 (PGE 2 ) (TPF PD ). We showed that F PD hold stronger inflammatory potency than pure αSYN fibrils generated de novo. When combined with TNFα and PGE 2 , F PD polarizes microglia toward a particular functional phenotype departing from F PD -treated cells and featuring lower inflammatory cytokine and higher glutamate release. Whereas metabolomic studies showed that TPF PD -exposed microglia were closely related to classically activated M1 proinflammatory cells, notably with similar tricarboxylic acid cycle disruption, transcriptomic analysis revealed that TPF PD -activated microglia assume a unique molecular signature highlighting upregulation of genes involved in glutathione and iron metabolisms. In particular, TPF PD -specific upregulation of Slc7a11 (which encodes the cystine-glutamate antiporter xCT) was consistent with the increased glutamate response and cytotoxic activity of these cells toward midbrain dopaminergic neurons in vitro. Together, these data further extend the structure–pathological relationship of αSYN fibrillar polymorphs to their innate immune properties and demonstrate that PD-derived αSYN fibrils, TNFα and PGE 2 act in concert to drive microglial cell activation toward a specific and highly neurotoxic chronic-type inflammatory phenotype characterized by robust glutamate release and iron retention.

Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease

Role of Α-Synuclein in Microglia: Autophagy and Phagocytosis Balance Neuroinflammation in Parkinson’s Disease

Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy

Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease

Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson's disease

Emerging Role of Microglia in Inter-Cellular Transmission of Α-Synuclein in Parkinson’s Disease

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease

α‐synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson’s disease

The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease

Extracellular Α-Synuclein--a Possible Initiator of Inflammation in Parkinson's Disease.

Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease

alpha-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease

The Role of α-synuclein and Autophagy in Parkinson's disease

Association of Glial Activation and Α-Synuclein Pathology in Parkinson’s Disease

Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype

Aggregated -synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Association of Glial Activation and -Synuclein Pathology in Parkinson's Disease

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions

Microglial Autophagy in Alzheimer’s Disease and Parkinson’s Disease

Roles of α‐synuclein in gastrointestinal microbiome dysbiosis‐related Parkinson's disease progression (Review)